1-20 of 32
Noffar Bar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Target antigen density may impact clinical response in patients with relapsed/refractory multiple myeloma undergoing treatment with elotuzumab and belantamab mafodotin

Free
Francesca Albano, Sabrina Browning, Fangyong Li, Noffar Bar, Terri Parker, Tara Anderson, Erica Stevens, Jennifer VanOudenhove, Martin Matthews, Elan Gorshein, Jason Haldas, Ashita Talsania, Kert Sabbath, Stuart Seropian, Stephanie Halene, Fabiana Perna, Natalia Neparidze
Journal: Blood
Blood (2025) 146 (Supplement 1): 7578.
https://doi.org/10.1182/blood-2025-7578
Published: 2025
Journal Articles

Trial in progress: A phase 1b/2a study to evaluate mezigdomide in combination with elranatamab in patients with relapsed/refractory multiple myeloma

Free
Noffar Bar, Nizar J. Bahlis, Zihan Lin, Kevin Hsu, Jessica Katz, Colin Godwin, Luciano Costa
Journal: Blood
Blood (2025) 146 (Supplement 1): 8246.
https://doi.org/10.1182/blood-2025-8246
Published: 2025
Journal Articles

Pentostatin/TBI conditioning for allogeneic transplantation in T-cell lymphomas

Free
Cristian Taborda, Iris Isufi, Tarsheen Sethi, Noffar Bar, Lohith Gowda, Lynn Wilson, Michael Girardi, Kenneth Roberts, Stuart Seropian, Francine Foss
Journal: Blood
Blood (2025) 146 (Supplement 1): 2433.
https://doi.org/10.1182/blood-2025-2433
Published: 2025
Journal Articles

Prospective evaluation of an AI-powered clinical trial patient matching (CTPM) system in myelodysplastic syndromes (MDS) and multiple myeloma

Free
Cristian Taborda, Guannan Gong, Gabriella Douglas, Jessica Liu, Abel Incoom, Maximilian Stahl, Nikolai Podoltsev, Jan Philipp Bewersdorf, Theodore Getz, Jessica Stempel, Tariq Kewan, Luca Lanino, Aram Bidikian, Terri Parker, Noffar Bar, Sabrina Browning, Stephanie Halene, Natalia Neparidze, Amer Zeidan, Lourdes Mendez
Journal: Blood
Blood (2025) 146 (Supplement 1): 1086.
https://doi.org/10.1182/blood-2025-1086
Published: 2025
Journal Articles

Real-World Efficacy and Patient-Reported Quality of Life Outcomes with Daratumumab Regimens in Multiple Myeloma

Free
Sabrina L. Browning, Fangyong Li, Poy Theprungsirikul, Terri L. Parker, Noffar Bar, Smith Giri, Tara Anderson, Erica Stevens, Elan Gorshein, Kert D. Sabbath, Catherine Wei, Syed S. Ali, David H. Witt, Justin Persico, Ashita Talsania, Leena Rahmat, Wajih Zaheer Kidwai, Robert D. Legare, Johanna LaSala, Matthew Austin, Natalia Neparidze
Journal: Blood
Blood (2024) 144 (Supplement 1): 7831.
https://doi.org/10.1182/blood-2024-204150
Published: 2024
Journal Articles

Ciltacabtagene Autoleucel (Cilta-cel) Vs Standard of Care (SoC) in Patients with Lenalidomide (Len)-Refractory Multiple Myeloma (MM) after 1-3 Lines of Therapy: Minimal Residual Disease (MRD) Negativity in the Phase 3 Cartitude-4 Trial

Free
Rakesh Popat, Albert Oriol, Michele Cavo, Lionel Karlin, Irit Avivi Mazza, Wilfried Roeloffzen, Seok Jin Kim, Brea Lipe, Noffar Bar, Noemi Horvath, Andrew Spencer, Chang-Ki Min, Diana Chen, Quanlin Li, Katherine Li, Ana Slaughter, Carolina Lonardi, Nina Benachour, Arnab Ghosh, Martin Vogel, Nikoletta Lendvai, Tamar Lengil, Nitin Patel, Octavio Costa Filho, Erika Florendo, Yi Lin
Journal: Blood
Blood (2024) 144 (Supplement 1): 1032.
https://doi.org/10.1182/blood-2024-201533
Published: 2024
Journal Articles

Long-Term Benefits in Patient-Reported Outcomes and Time to Next Anti-Myeloma Therapy of Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care for Patients with Lenalidomide-Refractory Multiple Myeloma: Results from the Phase 3 Cartitude-4 Clinical Trial

Free
Noffar Bar, Roberto Mina, Anne K. Mylin, Hisayuki Yokoyama, Hila Magen, Winfried Alsdorf, Monique C. Minnema, Leyla O. Shune, Iris Isufi, Simon J Harrison, Urvi A. Shah, André De Champlain, Katharine S. Gries, Diana Chen, Quanlin Li, Tzu-Min Yeh, Ana Slaughter, Carolina Lonardi, Nina Benachour, Arnab Ghosh, William Deraedt, Martin Vogel, Nikoletta Lendvai, Nitin Patel, Octavio Costa Filho, Erika Florendo, Lionel Karlin, Katja C. Weisel
Journal: Blood
Blood (2024) 144 (Supplement 1): 2002.
https://doi.org/10.1182/blood-2024-209232
Published: 2024
Journal Articles

Updated Comparative Efficacy of Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 2-4 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison

Free
Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden, João Mendes, Seina Lee, Teresa Hernando, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J Harrison, Urvi A. Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 3390.
https://doi.org/10.1182/blood-2024-201568
Published: 2024
Journal Articles

Weekly Bortezomib Decreases Rates of Peripheral Neuropathy without Diminishing Efficacy As Compared to Twice Weekly Bortezomib in Combination with Lenalidomide, Dexamethasone and Daratumumab

Free
Irvin Yi, Eleni Gaspar, William Eighmy, Heidi Roeder, Noffar Bar
Journal: Blood
Blood (2024) 144 (Supplement 1): 7004.
https://doi.org/10.1182/blood-2024-199190
Published: 2024
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study

Free
Noffar Bar, Maria Victoria Mateos, Paz Ribas, Markus Hansson, Laura Paris, Craig C. Hofmeister, Paula Rodriguez Otero, Maria Aranzazu Bermúdez, Thomas Martin, Armando Santoro, Andrew J. Yee, Maria Creignou, Cristina Encinas Rodriguez, Claudio Cerchione, Javier De La Rubia, Albert Oriol, Heidi Waibel, Britta Besemer, Ethan Thompson, Brian Kiesel, Jinjie Chen, Alexander Chung, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 2011.
https://doi.org/10.1182/blood-2023-180013
Published: 2023
Journal Articles

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 2-4 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison

Free
Noffar Bar, Joris Diels, Suzy van Sanden, João Mendes, Teresa Hernando, Patricia Cost, Jordan M. Schecter, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J. Harrison, Nieves Lopez-Muñoz
Journal: Blood
Blood (2023) 142 (Supplement 1): 2141.
https://doi.org/10.1182/blood-2023-182141
Published: 2023
Journal Articles

CAR T-Related Toxicities Based on Dynamic Proteomic Profiles Identifies Risk Factors for Cytokine Release Syndrome (CRS) and Immune Effector Cell -Associated Neurotoxicity Syndrome (ICANS)

Free
Tariq Kewan, Sayeef Mirza, Alexander B Pine, Yusuf Rasheed, Ramzi Hamouche, Etienne Leveille, George Goshua, Sean X Gu, Yuxin Liu, Jennifer Vanoudenhove, Noffar Bar, Natalia Neparidze, Francine M. Foss, Lohith Gowda, Iris Isufi, Stephanie Halene, Alfred I Lee, Stuart Seropian
Journal: Blood
Blood (2023) 142 (Supplement 1): 2132.
https://doi.org/10.1182/blood-2023-187295
Published: 2023
Journal Articles

Comprehensive Characterization of Coagulation Parameters in Venous Malformations

Free
Valentina Restrepo, Alexander B Pine, Ayesha Butt, Eric Y Chang, Noffar Bar, Audrey Baluha, Andrea Brooks, Giavanna Chirico, Jeffrey Curran, Anne Dumont, Pauline Obura-Wilkes, Henry M Rinder, Christopher Tormey, Naiem Nassiri, Alfred I Lee, Stephanie Prozora
Journal: Blood
Blood (2023) 142 (Supplement 1): 27.
https://doi.org/10.1182/blood-2023-190609
Published: 2023
Journal Articles

Evaluation of Metabolic Profile in Monoclonal Gammopathy of Undetermined Significance and Asymptomatic Multiple Myeloma

Free
Sabrina L. Browning, Allison J. Li, Terri L. Parker, Noffar Bar, Tara Anderson, Erica Stevens, Yuxin Liu, Martin Matthews, Jennifer VanOudenhove, Rebecca Cardone, Qiushi Sun, Robert Hale, Stephanie Halene, Richard Kibbey, Natalia Neparidze
Journal: Blood
Blood (2023) 142 (Supplement 1): 4774.
https://doi.org/10.1182/blood-2023-186401
Published: 2023
Journal Articles

Predictors of Outcome for Allogeneic Stem Cell Transplantation with a Reduced Intensity Pentostatin/TBI Conditioning Regimen in T-Cell Lymphomas: A Single Center Experience

Free
Ramzi Hamouche, Francine M. Foss, Sayeef Mirza, Mengyang Di, Iris Isufi, Noffar Bar, Lohith Gowda, Sarah Perreault, Kenneth Roberts, Stuart Seropian, Tarsheen Sethi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2172.
https://doi.org/10.1182/blood-2023-189414
Published: 2023
Journal Articles

Multimodality Platelet Evaluation By Mass Cytometry and Genetic Analysis in Patients with Bleeding Disorders

Free
Sean X Gu, Patrick G Gallagher, Ayesha Butt, Vivian W Gu, Kimberly Lezon-Geyda, Vincent P Schulz, Stephanie Prozora, Alfred I Lee, Natalia Neparidze, Noffar Bar, Kelsey Martin, Jennifer Cornell, Giavanna Chirico, Raja Chakraborty, Henry M Rinder, John Hwa, Robert D Bona
Journal: Blood
Blood (2023) 142 (Supplement 1): 1197.
https://doi.org/10.1182/blood-2023-177946
Published: 2023
Journal Articles

Enhanced Global Disease Assessment with Advanced Imaging and Targeted Myeloma Lesion Biopsy Highlights Spatial Heterogeneity and Detects Residual Disease in Multiple Myeloma

Free
Sabrina L. Browning, Yuxin Liu, Terri L. Parker, Noffar Bar, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Ria Syam, Elan Gorshein, Autumn DiAdamo, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Wei Wei, Andrew Haims, Natalia Neparidze
Journal: Blood
Blood (2022) 140 (Supplement 1): 7308–7310.
https://doi.org/10.1182/blood-2022-166325
Published: 2022
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Free
Sandy W. Wong, Noffar Bar, Laura Paris, Craig C Hofmeister, Markus Hansson, Armando Santoro, Maria-Victoria Mateos, Paula Rodríguez-Otero, Johan Lund, Cristina Encinas, Andrew J. Yee, Albert Oriol, Claudio Cerchione, Javier de la Rubia, Barbara Ferstl, Kristina Carlson, Paz Ribas, Arancha Bermúdez, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 400–402.
https://doi.org/10.1182/blood-2022-159009
Published: 2022
Journal Articles

Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel

Free
Abu-Sayeef Mirza, Alexander Pine, Yusuf Rasheed, Ramzi Hamouche, Etienne Leveille, George Goshua, Sean Gu, Yuxin Liu, Jennifer VanOudenhove, Noffar Bar, Natalia Neparidze, Francine M. Foss, Lohith Gowda, Iris Isufi, Stephanie Halene, Alfred I Lee, Stuart Seropian
Journal: Blood
Blood (2022) 140 (Supplement 1): 10410–10412.
https://doi.org/10.1182/blood-2022-168374
Published: 2022
Journal Articles

Genomic Sequencing of Paired Bone Marrow and Focal Lesion Biopsies of Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy

Free
Yuxin Liu, Sabrina L. Browning, Jennifer VanOudenhove, Giulia Biancon, Noffar Bar, Terri L. Parker, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Elan Gorshein, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Andrew Haims, Wei Wei, Natalia Neparidze
Journal: Blood
Blood (2022) 140 (Supplement 1): 7086–7087.
https://doi.org/10.1182/blood-2022-168109
Published: 2022